Added to YB: 2024-05-13
Pitch date: 2024-05-13
CRDL [bullish]
Cardiol Therapeutics Inc.
-41.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
Market Cap
CAD 204.7M
Pitch Price
CAD 2.24
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.99
P/E
-4.70
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Cardiol Therapeutics Inc. Class A CRDL
A summary for this pitch has not been created yet.
Read full article (0 min)